Role of age, sex, and specific provoking factors on the distal versus proximal presentation of first symptomatic deep vein thrombosis: analysis of the SWIss Venous ThromboEmbolism Registry (SWIVTER).


Journal

Internal and emergency medicine
ISSN: 1970-9366
Titre abrégé: Intern Emerg Med
Pays: Italy
ID NLM: 101263418

Informations de publication

Date de publication:
04 2022
Historique:
received: 23 06 2021
accepted: 24 10 2021
pubmed: 4 11 2021
medline: 22 4 2022
entrez: 3 11 2021
Statut: ppublish

Résumé

We aimed to evaluate the impact of age, sex, and their interactions with provoking risk factors for deep vein thrombosis (DVT). In addition, we intended to provide additional insights on risk factors associated with the isolated distal versus proximal presentation of first symptomatic acute DVT, both being characterized by different prognosis. In the present analysis from the SWIss Venous ThromboEmbolism Registry (SWIVTER), we compared demographic and baseline characteristics in patients with isolated distal (n = 184; 35%) versus proximal (n = 346) DVT of the lower limbs without symptomatic pulmonary embolism, and identified factors related with the presenting thrombosis location. In the overall population, mean age was 59 ± 19 years, 266 (50%) were women, 106 (20%) patients had cancer, 86 (16%) recent surgery, and 52 (10%) acute infection/sepsis. In a multivariable analysis, recent surgery [odds ratio (OR) 2.92, 95% confidence interval (CI) 1.80-4.73] was independently associated with a diagnosis of isolated distal DVT, whereas cancer (OR 2.01, 95% CI 1.20-3.35), male sex aged 41 to 75 years (OR 2.21, 95% CI 1.33-3.67), and acute infection/sepsis (OR 2.71, 95% CI 1.29-5.66) with a diagnosis of proximal DVT. In SWIVTER, age, sex, and several provoking risk factors for VTE appeared to be related with the presenting location of first symptomatic DVT. Cancer, male sex, and acute infection/sepsis were associated with a proximal location of DVT, whereas recent surgery was associated with a distal presentation, likely acting as confounders for the association between thrombosis location and prognosis.

Identifiants

pubmed: 34731428
doi: 10.1007/s11739-021-02878-7
pii: 10.1007/s11739-021-02878-7
pmc: PMC9018645
doi:

Substances chimiques

Anticoagulants 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

799-803

Informations de copyright

© 2021. The Author(s).

Références

Kyrle PA, Kammer M, Eischer L, Weltermann A, Minar E, Hirschl M et al (2016) The long-term recurrence risk of patients with unprovoked venous thromboembolism: an observational cohort study. J Thromb Haemost 14(12):2402–2409
doi: 10.1111/jth.13524 pubmed: 27696701
Palareti G (2014) How I treat isolated distal deep vein thrombosis (IDDVT). Blood 123(12):1802–1809
doi: 10.1182/blood-2013-10-512616 pubmed: 24472834
Barco S, Klok FA, Mahé I, Marchena PJ, Ballaz A, Rubio CM et al (2019) Impact of sex, age, and risk factors for venous thromboembolism on the initial presentation of first isolated symptomatic acute deep vein thrombosis. Thromb Res 173:166–171
doi: 10.1016/j.thromres.2018.09.056 pubmed: 30385047
Trinchero A, Scheres LJJ, Prochaska JH, Ambaglio C, Wild PS, Middeldorp S et al (2018) Sex-specific differences in the distal versus proximal presenting location of acute deep vein thrombosis. Thromb Res 172:74–79
doi: 10.1016/j.thromres.2018.10.025 pubmed: 30384038
Spirk D, Sebastian T, Barco S, Banyai M, Beer JH, Mazzolai L et al (2020) Clinical outcomes of incidental venous thromboembolism in cancer and noncancer patients: the SWIss venous ThromboEmbolism Registry (SWIVTER). Thromb Haemost. https://doi.org/10.1055/s-0040-1720977
doi: 10.1055/s-0040-1720977 pubmed: 33202448
Kearon C, Akl EA, Ornelas J, Blaivas A, Jimenez D, Bounameaux H et al (2016) Antithrombotic therapy for VTE disease: CHEST guideline and expert panel report. Chest 149:315–352
doi: 10.1016/j.chest.2015.11.026 pubmed: 26867832
Barco S, Corti M, Trinchero A, Picchi C, Ambaglio C, Konstantinides SV et al (2017) Survival and recurrent venous thromboembolism in patients with first proximal or isolated distal deep vein thrombosis and no pulmonary embolism. J Thromb Haemost 15(7):1436–1442
doi: 10.1111/jth.13713 pubmed: 28439954
Bauersachs RM, Riess H, Hach-Wunderle V, Gerlach H, Carnarius H, Eberle S et al (2010) Impact of gender on the clinical presentation and diagnosis of deep-vein thrombosis. Thromb Haemost 103(4):710–717
doi: 10.1160/TH09-10-0705 pubmed: 20174769
Schellong SM, Goldhaber SZ, Weitz JI, Ageno W, Bounameaux H, Turpie AGG et al (2019) Isolated distal deep vein thrombosis: perspectives from the GARFIELD-VTE registry. Thromb Haemost 119(10):1675–1685
doi: 10.1055/s-0039-1693461 pubmed: 31370075

Auteurs

David Spirk (D)

Institute of Pharmacology, University of Bern, Bern, Switzerland.

Tim Sebastian (T)

Department of Angiology, University Hospital Zurich, Raemistrasse 100, RAE C 13, 8091, Zurich, Switzerland.

Jürg Hans Beer (JH)

Department of Internal Medicine, Cantonal Hospital Baden, Baden, Switzerland.

Lucia Mazzolai (L)

Clinic of Angiology, University Hospital Lausanne, Lausanne, Switzerland.

Drahomir Aujesky (D)

Division of General Internal Medicine, Bern University Hospital and University of Bern, Bern, Switzerland.

Daniel Hayoz (D)

Department of Internal Medicine and Division of Angiology, Cantonal Hospital Fribourg, Fribourg, Switzerland.

Rolf Peter Engelberger (RP)

Department of Internal Medicine and Division of Angiology, Cantonal Hospital Fribourg, Fribourg, Switzerland.

Wolfgang Korte (W)

Department of Internal Medicine, Cantonal Hospital St. Gallen, St. Gallen, Switzerland.

Nils Kucher (N)

Department of Angiology, University Hospital Zurich, Raemistrasse 100, RAE C 13, 8091, Zurich, Switzerland.

Stefano Barco (S)

Department of Angiology, University Hospital Zurich, Raemistrasse 100, RAE C 13, 8091, Zurich, Switzerland. stefano.barco@usz.ch.
Center for Thrombosis and Hemostasis, University Medical Center Mainz, Mainz, Germany. stefano.barco@usz.ch.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH